For patients with rare diseases, the path to diagnosis can be long and difficult. But, as a new policy paper from the European Alliance for Patient Access notes, that’s only one of several hurdles that patients face.
World leaders are squaring off on a complex topic: whether to temporarily waive intellectual property rights for COVID-19 vaccines.
A new organisation aims to fill the gap between health care data and health care reality. How? By embracing real-world evidence.
Just as COVID-19 drove people to distance themselves, widespread vaccination has the potential to bring them closer. But as the World Health Organization celebrates World Immunization Week, COVID-19 vaccination across Europe remains a challenge.
International and regional organisations are taking a stand for the billions of people living with neurological conditions.
If this is the Decade of Health Ageing, as the World Health Organization declares, then heart failure may well be the next public health crisis.
A common cardiovascular risk factor that affects one-fourth of the world’s population may be overlooked by health care providers – and unknown to the general public.
In Europe, young patients and health care professionals have decided that now is the time to seek better health policies. I saw this first-hand at February’s #RARE2030 rare disease policy conference.